A Novel Apolipoprotein C-II Mimetic Peptide That Activates Lipoprotein Lipase and Decreases Serum Triglycerides in Apolipoprotein E–Knockout Mice

Apolipoprotein A-I (apoA-I) mimetic peptides are currently being developed as possible new agents for the treatment of cardiovascular disease based on their ability to promote cholesterol efflux and their other beneficial antiatherogenic properties. Many of these peptides, however, have been reporte...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:J Pharmacol Exp Ther
المؤلفون الرئيسيون: Amar, Marcelo J. A., Sakurai, Toshihiro, Sakurai-Ikuta, Akiko, Sviridov, Denis, Freeman, Lita, Ahsan, Lusana, Remaley, Alan T.
التنسيق: Artigo
اللغة:Inglês
منشور في: The American Society for Pharmacology and Experimental Therapeutics 2015
الموضوعات:
Cardiovascular
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293430/
https://ncbi.nlm.nih.gov/pubmed/25395590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.114.220418
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة